A computerized system for signal detection in spontaneous reporting system of Shanghai China

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 2, 2009, Pages 154-158

  Ye, Xiaofei ^a   Fu, Zheng ^a   Wang, Hainan ^a,b   Du, Wenmin ^c   Wang, Rui ^a   Sun, Yalin ^a   Gao, Qingbin ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Center for Drug Evaluation State Food and Drug Administration   (China)

^c Adverse Drug Reaction Monitoring Centre of Shanghai   (China)

Author keywords

Adverse drug reaction; Data mining; Signal detection; Spontaneous reporting system

Indexed keywords

CAPTOPRIL; CHINESE DRUG; GENERIC DRUG; PYRAZINAMIDE; UNCLASSIFIED DRUG; YUXINGCAO;

ARTICLE; CHINA; COMPUTER SYSTEM; COUGHING; CYANOSIS; DATA MINING; DRUG SURVEILLANCE PROGRAM; HEMATURIA; HEPATITIS; HUMAN; INFORMATION PROCESSING; MEDICAL INFORMATION SYSTEM; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT; ALGORITHM; ARTIFICIAL NEURAL NETWORK; BAYES THEOREM; FACTUAL DATABASE; MEDICAL RECORD; ORGANIZATION AND MANAGEMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; BAYES THEOREM; CHINA; DATABASES, FACTUAL; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NEURAL NETWORKS (COMPUTER);

EID: 62649105797     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1695     Document Type: Article

References (16)

1. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2003; 57: 127-134.
2. Hauben M, Reich L. Communication of findings in pharmacovigilance: use of the term 'signal' and the need for precision in its use. Eur J Clin Pharmacol 2005; 61: 479-480.
3. Hauben M, Horn S, Reich L. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions. Drug Saf 2007; 30(2): 143-155.
4. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4: 929-948.
5. Bousquet C, Henegar C, Lillo-Le Louet A, Degoulet P, Jaulent MC. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach. Int J Med Inform 2005; 74: 563-571.
6. Lindquist M. Use of triage strategies in the WHO signal-detection process. Drug Saf 2007; 30(7): 635-637.
7. National Adverse Drug Reaction Monitoring Center. WHO Adverse Reaction Terminology. China Medicine and Technology Press: Peking, 2003.
8. Committee of Chinese Pharmacopoeia. Chinese Pharmacopoeia. Chemical Industry Press: Peking, 2005.
9. Hauben M, Xiaofeng Z. Quantitative methods in pharmacovigilance: focus on signal detection. Drug saf 2003; 26(3): 159-186.
10. Stephenson WP, Hauben M. Data mining for signals in spontaneous reporting databases: proceed with caution. Pharmacoepidemiol Drug Saf 2007; 16: 359-365.
11. Hauben M, Patadia VK, Goldsmith D. What counts in data mining. Drug saf 2006; 29(10): 827-832.
12. Li C, Xia J, Deng J, Jiang J. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China. Pharmacoepidemiol Drug Saf 2008; 17(6): 593-600.
13. Bate A, Lindquist M, Orre R, Edwards IR, Meyboom RH. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. Eur J Clin Pharmacol 2002; 58: 483-490.
14. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-321.
15. van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting system for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10.
16. Du W, Levine M, Wang L, Zhang Y, Yi C, Wang H, et al. Building a structured monitoring and evaluating system of post-marketing drug use in Shanghai. Can J Clin Pharmacol 2007; 14(1): e40-e44.